Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus
Full Text Available
The authors disclose the following: Supported by NIH grant CA102599. Drs Lewis, Habel, Ferrara, and Quesenberry have received research funding from Takeda. Dr Lewis has received research support from GlaxoSmithKline. Drs Habel and Ferrara have received research support from Eli Lilly. Dr Habel has also received research support from Merck.
PII: S0016-5085(08)01667-3
doi:10.1053/j.gastro.2008.09.004
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.


